Table of Content

1 PD1&PDL1 Inhibitors Market Overview
1.1 Product Overview and Scope of PD1&PDL1 Inhibitors
1.2 PD1&PDL1 Inhibitors Segment by Type
1.2.1 Global PD1&PDL1 Inhibitors Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 PD1 Inhibitors
1.2.3 PDL1 Inhibitors
1.3 PD1&PDL1 Inhibitors Segment by Application
1.3.1 PD1&PDL1 Inhibitors Sales Comparison by Application: (2021-2027)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global PD1&PDL1 Inhibitors Market Size Estimates and Forecasts
1.4.1 Global PD1&PDL1 Inhibitors Revenue 2016-2027
1.4.2 Global PD1&PDL1 Inhibitors Sales 2016-2027
1.4.3 PD1&PDL1 Inhibitors Market Size by Region: 2016 Versus 2021 Versus 2027

2 PD1&PDL1 Inhibitors Market Competition by Manufacturers
2.1 Global PD1&PDL1 Inhibitors Sales Market Share by Manufacturers (2016-2021)
2.2 Global PD1&PDL1 Inhibitors Revenue Market Share by Manufacturers (2016-2021)
2.3 Global PD1&PDL1 Inhibitors Average Price by Manufacturers (2016-2021)
2.4 Manufacturers PD1&PDL1 Inhibitors Manufacturing Sites, Area Served, Product Type
2.5 PD1&PDL1 Inhibitors Market Competitive Situation and Trends
2.5.1 PD1&PDL1 Inhibitors Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest PD1&PDL1 Inhibitors Players Market Share by Revenue
2.5.3 Global PD1&PDL1 Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 PD1&PDL1 Inhibitors Retrospective Market Scenario by Region
3.1 Global PD1&PDL1 Inhibitors Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global PD1&PDL1 Inhibitors Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America PD1&PDL1 Inhibitors Market Facts & Figures by Country
3.3.1 North America PD1&PDL1 Inhibitors Sales by Country
3.3.2 North America PD1&PDL1 Inhibitors Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe PD1&PDL1 Inhibitors Market Facts & Figures by Country
3.4.1 Europe PD1&PDL1 Inhibitors Sales by Country
3.4.2 Europe PD1&PDL1 Inhibitors Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific PD1&PDL1 Inhibitors Market Facts & Figures by Region
3.5.1 Asia Pacific PD1&PDL1 Inhibitors Sales by Region
3.5.2 Asia Pacific PD1&PDL1 Inhibitors Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America PD1&PDL1 Inhibitors Market Facts & Figures by Country
3.6.1 Latin America PD1&PDL1 Inhibitors Sales by Country
3.6.2 Latin America PD1&PDL1 Inhibitors Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa PD1&PDL1 Inhibitors Market Facts & Figures by Country
3.7.1 Middle East and Africa PD1&PDL1 Inhibitors Sales by Country
3.7.2 Middle East and Africa PD1&PDL1 Inhibitors Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global PD1&PDL1 Inhibitors Historic Market Analysis by Type
4.1 Global PD1&PDL1 Inhibitors Sales Market Share by Type (2016-2021)
4.2 Global PD1&PDL1 Inhibitors Revenue Market Share by Type (2016-2021)
4.3 Global PD1&PDL1 Inhibitors Price by Type (2016-2021)

5 Global PD1&PDL1 Inhibitors Historic Market Analysis by Application
5.1 Global PD1&PDL1 Inhibitors Sales Market Share by Application (2016-2021)
5.2 Global PD1&PDL1 Inhibitors Revenue Market Share by Application (2016-2021)
5.3 Global PD1&PDL1 Inhibitors Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Bristol-Myers Squibb
6.1.1 Bristol-Myers Squibb Corporation Information
6.1.2 Bristol-Myers Squibb Description and Business Overview
6.1.3 Bristol-Myers Squibb PD1&PDL1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Bristol-Myers Squibb Product Portfolio
6.1.5 Bristol-Myers Squibb Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck PD1&PDL1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Merck Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Roche
6.3.1 Roche Corporation Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche PD1&PDL1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Roche Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer PD1&PDL1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Pfizer Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca PD1&PDL1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
6.5.4 AstraZeneca Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Ono Pharmaceutical
6.6.1 Ono Pharmaceutical Corporation Information
6.6.2 Ono Pharmaceutical Description and Business Overview
6.6.3 Ono Pharmaceutical PD1&PDL1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Ono Pharmaceutical Product Portfolio
6.6.5 Ono Pharmaceutical Recent Developments/Updates

7 PD1&PDL1 Inhibitors Manufacturing Cost Analysis
7.1 PD1&PDL1 Inhibitors Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of PD1&PDL1 Inhibitors
7.4 PD1&PDL1 Inhibitors Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 PD1&PDL1 Inhibitors Distributors List
8.3 PD1&PDL1 Inhibitors Customers

9 PD1&PDL1 Inhibitors Market Dynamics
9.1 PD1&PDL1 Inhibitors Industry Trends
9.2 PD1&PDL1 Inhibitors Growth Drivers
9.3 PD1&PDL1 Inhibitors Market Challenges
9.4 PD1&PDL1 Inhibitors Market Restraints

10 Global Market Forecast
10.1 PD1&PDL1 Inhibitors Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of PD1&PDL1 Inhibitors by Type (2022-2027)
10.1.2 Global Forecasted Revenue of PD1&PDL1 Inhibitors by Type (2022-2027)
10.2 PD1&PDL1 Inhibitors Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of PD1&PDL1 Inhibitors by Application (2022-2027)
10.2.2 Global Forecasted Revenue of PD1&PDL1 Inhibitors by Application (2022-2027)
10.3 PD1&PDL1 Inhibitors Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of PD1&PDL1 Inhibitors by Region (2022-2027)
10.3.2 Global Forecasted Revenue of PD1&PDL1 Inhibitors by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global PD1&PDL1 Inhibitors Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global PD1&PDL1 Inhibitors Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global PD1&PDL1 Inhibitors Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers PD1&PDL1 Inhibitors Covered in This Study
Table 5. Global PD1&PDL1 Inhibitors Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global PD1&PDL1 Inhibitors Sales Share by Manufacturers (2016-2021)
Table 7. Global PD1&PDL1 Inhibitors Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global PD1&PDL1 Inhibitors Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market PD1&PDL1 Inhibitors Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers PD1&PDL1 Inhibitors Manufacturing Sites and Area Served
Table 11. Manufacturers PD1&PDL1 Inhibitors Product Type
Table 12. Global PD1&PDL1 Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global PD1&PDL1 Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PD1&PDL1 Inhibitors as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global PD1&PDL1 Inhibitors Sales by Region (2016-2021) & (K Units)
Table 16. Global PD1&PDL1 Inhibitors Sales Market Share by Region (2016-2021)
Table 17. Global PD1&PDL1 Inhibitors Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America PD1&PDL1 Inhibitors Sales by Country (2016-2021) & (K Units)
Table 19. North America PD1&PDL1 Inhibitors Sales Market Share by Country (2016-2021)
Table 20. North America PD1&PDL1 Inhibitors Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America PD1&PDL1 Inhibitors Revenue Market Share by Country (2016-2021)
Table 22. Europe PD1&PDL1 Inhibitors Sales by Country (2016-2021) & (K Units)
Table 23. Europe PD1&PDL1 Inhibitors Sales Market Share by Country (2016-2021)
Table 24. Europe PD1&PDL1 Inhibitors Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe PD1&PDL1 Inhibitors Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific PD1&PDL1 Inhibitors Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific PD1&PDL1 Inhibitors Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific PD1&PDL1 Inhibitors Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific PD1&PDL1 Inhibitors Revenue Market Share by Region (2016-2021)
Table 30. Latin America PD1&PDL1 Inhibitors Sales by Country (2016-2021) & (K Units)
Table 31. Latin America PD1&PDL1 Inhibitors Sales Market Share by Country (2016-2021)
Table 32. Latin America PD1&PDL1 Inhibitors Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America PD1&PDL1 Inhibitors Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa PD1&PDL1 Inhibitors Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa PD1&PDL1 Inhibitors Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa PD1&PDL1 Inhibitors Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa PD1&PDL1 Inhibitors Revenue Market Share by Country (2016-2021)
Table 38. Global PD1&PDL1 Inhibitors Sales (K Units) by Type (2016-2021)
Table 39. Global PD1&PDL1 Inhibitors Sales Market Share by Type (2016-2021)
Table 40. Global PD1&PDL1 Inhibitors Revenue (Million US$) by Type (2016-2021)
Table 41. Global PD1&PDL1 Inhibitors Revenue Share by Type (2016-2021)
Table 42. Global PD1&PDL1 Inhibitors Price (US$/Unit) by Type (2016-2021)
Table 43. Global PD1&PDL1 Inhibitors Sales (K Units) by Application (2016-2021)
Table 44. Global PD1&PDL1 Inhibitors Sales Market Share by Application (2016-2021)
Table 45. Global PD1&PDL1 Inhibitors Revenue (Million US$) by Application (2016-2021)
Table 46. Global PD1&PDL1 Inhibitors Revenue Share by Application (2016-2021)
Table 47. Global PD1&PDL1 Inhibitors Price (US$/Unit) by Application (2016-2021)
Table 48. Bristol-Myers Squibb Corporation Information
Table 49. Bristol-Myers Squibb Description and Business Overview
Table 50. Bristol-Myers Squibb PD1&PDL1 Inhibitors Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Bristol-Myers Squibb PD1&PDL1 Inhibitors Product
Table 52. Bristol-Myers Squibb Recent Developments/Updates
Table 53. Merck Corporation Information
Table 54. Merck Description and Business Overview
Table 55. Merck PD1&PDL1 Inhibitors Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Merck PD1&PDL1 Inhibitors Product
Table 57. Merck Recent Developments/Updates
Table 58. Roche Corporation Information
Table 59. Roche Description and Business Overview
Table 60. Roche PD1&PDL1 Inhibitors Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Roche PD1&PDL1 Inhibitors Product
Table 62. Roche Recent Developments/Updates
Table 63. Pfizer Corporation Information
Table 64. Pfizer Description and Business Overview
Table 65. Pfizer PD1&PDL1 Inhibitors Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Pfizer PD1&PDL1 Inhibitors Product
Table 67. Pfizer Recent Developments/Updates
Table 68. AstraZeneca Corporation Information
Table 69. AstraZeneca Description and Business Overview
Table 70. AstraZeneca PD1&PDL1 Inhibitors Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. AstraZeneca PD1&PDL1 Inhibitors Product
Table 72. AstraZeneca Recent Developments/Updates
Table 73. Ono Pharmaceutical Corporation Information
Table 74. Ono Pharmaceutical Description and Business Overview
Table 75. Ono Pharmaceutical PD1&PDL1 Inhibitors Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Ono Pharmaceutical PD1&PDL1 Inhibitors Product
Table 77. Ono Pharmaceutical Recent Developments/Updates
Table 78. Production Base and Market Concentration Rate of Raw Material
Table 79. Key Suppliers of Raw Materials
Table 80. PD1&PDL1 Inhibitors Distributors List
Table 81. PD1&PDL1 Inhibitors Customers List
Table 82. PD1&PDL1 Inhibitors Market Trends
Table 83. PD1&PDL1 Inhibitors Growth Drivers
Table 84. PD1&PDL1 Inhibitors Market Restraints
Table 85. Global PD1&PDL1 Inhibitors Sales Forecast by Type (2022-2027) & (K Units)
Table 86. Global PD1&PDL1 Inhibitors Sales Market Share Forecast by Type (2022-2027)
Table 87. Global PD1&PDL1 Inhibitors Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 88. Global PD1&PDL1 Inhibitors Revenue Market Share Forecast by Type (2022-2027)
Table 89. Global PD1&PDL1 Inhibitors Sales Forecast by Application (2022-2027) & (K Units)
Table 90. Global PD1&PDL1 Inhibitors Sales Market Share Forecast by Application (2022-2027)
Table 91. Global PD1&PDL1 Inhibitors Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 92. Global PD1&PDL1 Inhibitors Revenue Market Share Forecast by Application (2022-2027)
Table 93. Global PD1&PDL1 Inhibitors Sales Forecast by Region (2022-2027) & (K Units)
Table 94. Global PD1&PDL1 Inhibitors Sales Market Share Forecast by Region (2022-2027)
Table 95. Global PD1&PDL1 Inhibitors Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 96. Global PD1&PDL1 Inhibitors Revenue Market Share Forecast by Region (2022-2027)
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of PD1&PDL1 Inhibitors
Figure 2. Global PD1&PDL1 Inhibitors Market Share by Type in 2020 & 2027
Figure 3. PD1 Inhibitors Product Picture
Figure 4. PDL1 Inhibitors Product Picture
Figure 5. Global PD1&PDL1 Inhibitors Market Share by Application in 2020 & 2027
Figure 6. Hospital Pharmacies
Figure 7. Retail Pharmacies
Figure 8. Online Pharmacies
Figure 9. Global PD1&PDL1 Inhibitors Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global PD1&PDL1 Inhibitors Market Size 2016-2027 (US$ Million)
Figure 11. Global PD1&PDL1 Inhibitors Sales 2016-2027 (K Units)
Figure 12. Global PD1&PDL1 Inhibitors Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. PD1&PDL1 Inhibitors Sales Share by Manufacturers in 2020
Figure 14. Global PD1&PDL1 Inhibitors Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest PD1&PDL1 Inhibitors Players: Market Share by Revenue in 2020
Figure 16. PD1&PDL1 Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global PD1&PDL1 Inhibitors Sales Market Share by Region (2016-2021)
Figure 18. Global PD1&PDL1 Inhibitors Sales Market Share by Region in 2020
Figure 19. Global PD1&PDL1 Inhibitors Revenue Market Share by Region (2016-2021)
Figure 20. Global PD1&PDL1 Inhibitors Revenue Market Share by Region in 2020
Figure 21. U.S. PD1&PDL1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada PD1&PDL1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany PD1&PDL1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France PD1&PDL1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. PD1&PDL1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy PD1&PDL1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia PD1&PDL1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China PD1&PDL1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan PD1&PDL1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea PD1&PDL1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India PD1&PDL1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia PD1&PDL1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan PD1&PDL1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia PD1&PDL1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand PD1&PDL1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia PD1&PDL1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines PD1&PDL1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam PD1&PDL1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico PD1&PDL1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil PD1&PDL1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina PD1&PDL1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey PD1&PDL1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia PD1&PDL1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE PD1&PDL1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of PD1&PDL1 Inhibitors by Type (2016-2021)
Figure 46. Sales Market Share of PD1&PDL1 Inhibitors by Application (2016-2021)
Figure 47. Sales Market Share of PD1&PDL1 Inhibitors by Application in 2020
Figure 48. Revenue Share of PD1&PDL1 Inhibitors by Application (2016-2021)
Figure 49. Revenue Share of PD1&PDL1 Inhibitors by Application in 2020
Figure 50. Manufacturing Cost Structure of PD1&PDL1 Inhibitors
Figure 51. Manufacturing Process Analysis of PD1&PDL1 Inhibitors
Figure 52. PD1&PDL1 Inhibitors Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed